Page last updated: 2024-08-22

diallyl trisulfide and Lymphoma, Primary Effusion

diallyl trisulfide has been researched along with Lymphoma, Primary Effusion in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimuro, M; Furukawa, Y; Hosokawa, K; Kagawa, H; Matsuhiro, J; Minami, S; Nakagawa, K; Nakata, S; Shigemi, Z; Takeda, H; Watanabe, T1

Other Studies

1 other study(ies) available for diallyl trisulfide and Lymphoma, Primary Effusion

ArticleYear
Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
    International journal of oncology, 2016, Volume: 48, Issue:1

    Topics: Allyl Compounds; Animals; Apoptosis; Cell Line, Tumor; Humans; I-kappa B Kinase; I-kappa B Proteins; Intracellular Signaling Peptides and Proteins; Lymphoma, Primary Effusion; Mice; Neoplasm Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Phosphorylation; Proteolysis; Signal Transduction; Sulfides; Sulfones; Xenograft Model Antitumor Assays

2016